← All Ribbon Acquisition CORP filings

Ribbon Acquisition CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
RIBB
Ribbon Acquisition CORP
10-Q: Ribbon Acquisition Corp. Q2 2026 Update: Business Combination Progress Amidst Financial Concerns
Ribbon Acquisition Corporation's Q2 2026 Form 10-Q details ongoing efforts towards a business combination with DRC Medicine Ltd., while reporting a net loss and substantial doubt regarding its going concern status.
NASDAQ
RIBB
Ribbon Acquisition CORP
10-Q: Ribbon Acquisition Q1 2026 Financial Update
Ribbon Acquisition Corporation reports Q1 2026 financial results while continuing to pursue its business combination with DRC Medicine.
NASDAQ
RIBB
Ribbon Acquisition CORP
10-Q: Ribbon Acquisition Advances DRC Medicine Merger, Reports Q3 Net Income
Ribbon Acquisition Corporation reported a net income of $62,142 for Q3 2025 and $569,295 for the nine months, while advancing its business combination with AI-powered diagnostic company DRC Medicine.
NASDAQ
RIBB
Ribbon Acquisition CORP
10-Q: Ribbon Acquisition Corp. Q2 Net Income Rises, Announces DRC Medicine Merger
Ribbon Acquisition Corporation reported a net income of $271,297 for Q2 2025, driven by trust account interest, and announced a definitive business combination agreement with DRC Medicine Inc.
NASDAQ
RIBB
Ribbon Acquisition CORP
10-Q: Ribbon Acquisition Corp Reports Net Income of $235,856 for Q1 2025
Ribbon Acquisition Corp reports a net income of $235,856 for the quarter ended March 31, 2025, driven by income earned on marketable securities held in trust.